W. C. Heraeus GmbH has been one of the top names in industrial precious metal trading and processing for more than 155 years.
Since the early 1980s W.C. Heraeus’ Business Unit Pharmaceutical Ingredients specializes in the production of
generic APIs as well as the contract development and manufacture of
New Chemical Entities (NCEs). With a focus on highly potent anti-cancer Active Pharmaceutical Ingredients (hAPIs) for cancer therapy and traditionally coming from precious metal compounds like Cisplatin,Carboplatin and Oxaliplatin the Business Unit Pharmaceutical Ingredients today offers a variety of technical expertise.
Our capabilities range from precious metal compounds to organic chemistry and fermentation processes.
